Benefit #1: Reduced Risk of Major Cardiac Events Clinical trials have demonstrated that patients taking semaglutide experienced 20% fewer major cardiac events compared to those on placebo [10]
TRANSCEND-T2D-1 TRANSCEND-T2D-1, a randomized, double-blind, placebo-controlled phase 3 study, assessed the safety and efficacy of retatrutide monotherapy in adults with recent-onset type 2 diabetes who had inadequate glycemic management despite diet and exercise alone
And Ive personally known numerous vegans who neglected B12 and subsequently experienced fatigue and temporary neuropathy that resolved upon supplementation
Fidan-Yaylal, G., Dodurga, Y., Seme, M., & Elmas, L
A serious hypersensitivity reaction to semaglutide or to any of the excipients in OZEMPIC
10.31662/jmaj.2020-0005 JMA J